{"entity":{"id":"icesp","kind":"institution","name":"Instituto do Câncer do Estado de São Paulo (ICESP)","aka":["ICESP Octavio Frias de Oliveira","Hospital das Clínicas FMUSP"],"tldr":"ICESP is the São Paulo state cancer institute within Hospital das Clínicas and the University of São Paulo medical school; it treats patients only through Brazil's public health system, with 520 beds across four sites, and is the main Brazilian public-sector site for international trials.","summary":"ICESP was created by the State of São Paulo as the cancer institute of the Hospital das Clínicas of the Faculdade de Medicina da Universidade de São Paulo, managed by the Fundação Faculdade de Medicina, and treats patients exclusively through Brazil's public health system (SUS). In February 2026 the institute reported 520 operational beds, around 40,000 active patients and more than 150,000 patients treated since it opened, across four sites. It provides medical oncology, radiotherapy, surgical oncology, haematology, nuclear medicine and palliative care, hosts a large research and teaching programme in translational oncology, and is the principal Brazilian public-sector site for many international trials.","asOf":"2026-09-10","links":[{"label":"Official website","url":"https://www.icesp.org.br"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["inca-brazil","ac-camargo"],"pathways":[],"terms":[],"trials":[],"people":["arthur-violante-sapia"],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"São Paulo","country":"BR","lat":-23.556,"lng":-46.669,"institutionType":"cancer-center","website":"https://www.icesp.org.br","university":"Universidade de São Paulo","programs":["Public-sector cancer institute","Radiotherapy","Translational oncology research","Clinical trials"]},"route":"/institutions/icesp/","neighbours":{"institution":[{"id":"ac-camargo","kind":"institution","name":"A.C. Camargo Cancer Center","route":"/institutions/ac-camargo/"},{"id":"inca-brazil","kind":"institution","name":"Instituto Nacional de Câncer (INCA)","route":"/institutions/inca-brazil/"}],"person":[{"id":"arthur-violante-sapia","kind":"person","name":"Arthur Violante Sapia","route":"/people/arthur-violante-sapia/"}],"trial":[{"id":"nct04447235","kind":"trial","name":"Ivermectin plus losartan for COVID-19 in cancer patients (ICESP phase 2, terminated)","route":"/trials/nct04447235/"}]}}